LungBlog

Clinicians at the University of Pittsburgh Medical Center (UPMC) Cancer Centers successfully treated a lung cancer patient in her mid-fifties using a new more precise technique that combines image-guided radiotherapy (IGRT) with respiratory gating to zero in on her tumor while adapting for breathing motion.

Several U.S. studies find that a few well-chosen words from a nurse can play a part in convincing smokers to quit.

Results of the Southwest Oncology Group study, led by UC Davis Cancer Center researchers have shown that adding Bortezomib ( Velcade ) to a standard chemotherapy regimen of Gemcitabine and Carboplatin prolongs survival in patients with advanced non-small cell lung cancer.

This article is worth repeating.  It specifically addresses genetic profiling in determining which patients should receive chemotherapy after lung surgery.

This is another article on the use of the Cyberknife on those patients who are ineligible for surgery in treatment of lung cancer.

Currently available smoking cessation therapies have limited success rates. Varenicline tartrate is a novel, selective nicotinic receptor partial agonist developed specifically for smoking cessation.

According to the journal Lung Cancer, individuals with a history of emphysema and pneumonia have an increased risk of developing lung cancer. However, further study is needed to confirm these findings.

Swiss drugmaker Roche Holding AG said Tuesday it has filed its top-selling drug Avastin to Europe’s medical regulator, for approval for use as a treatment for the most common form of lung cancer.

Dogs can be trained to detect early and late stages of lung and breast cancer accurately according to a study published by California scientists in the little-known scientific journal Integrative Cancer Therapies.

According to an article recently published in the journal Thorax, the surgical removal of lung cancer (surgical resection) produces favorable survival rates among patients with lung cancer, even those with advanced stages of lung cancer.